Jan De Witte - 16 Nov 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
Director
Signature
Jan De Witte, director
Issuer symbol
RMD
Transactions as of
16 Nov 2022
Net transactions value
$0
Form type
4
Filing time
21 Nov 2022, 15:33:52 UTC
Previous filing
03 Nov 2022
Next filing
19 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ReMed Common Stock Award $0 +1,122 +22% $0.000000 6,111 16 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2023, or the annual shareholders meeting in the year following the grant date.